Metagone Biotech
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11號 行愛路77巷 3樓, Taipei City, Taipei, Taiw...Phone Number
+61 227906566Website
www.metagone.com.twRevenue
<$5 MillionIndustry
About Metagone Biotech
Metagone Biotech Org Chart
Is Metagone Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Metagone Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Metagone Biotech
Check out if Metagone Biotech is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Metagone Biotech recently announced quarterly report
Check if Metagone Biotech has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Metagone Biotech launches new products
Funding: Get notified immidiatlly once Metagone Biotech has new funding data
Metagone Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Metagone Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Metagone Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Metagone Biotech.
Metagone Biotech Tech Stack
A closer look at the technologies used by Metagone Biotech
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Metagone Biotech
信力生技, established on January 22, 2015, focuses on the research and development of new drugs, particularly targeting cancer treatments. The company has seen significant growth, increasing its capital from NT$40 million to NT$355.9 million and expanding its workforce from 5 to 20 employees, including 3 PhD holders and 14 master's degree holders. Thei... Read More